TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.470
-0.020 (-0.45%)
Apr 29, 2026, 11:26 AM EDT - Market open
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $274.52 million as of April 29, 2026. Its market cap has increased by 59.28% in one year.
Market Cap
274.52M
Enterprise Value
289.14M
1-Year Change
59.28%
Ranking
Category
Stock Price
$4.47
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $274.52M, a decrease of -16.50%. That is a compound annual growth rate of -3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 275.75M | -20.93% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delcath Systems | 363.32M |
| Standard BioTools | 361.25M |
| CapsoVision | 338.41M |
| ClearPoint Neuro | 332.25M |
| Senseonics Holdings | 300.15M |
| RxSight | 295.88M |
| 908 Devices | 251.94M |
| Profound Medical | 247.34M |